Aim & Scope
Current Hematologic Malignancy Reports provides in-depth review articles contributed by international experts on the most significant developments in the field. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the diagnosis, treatment, management, and prevention of conditions associated with hematologic malignancy. [1]
2024
Novel Approaches to Managing Patients with Relapsed and Refractory Waldenström Macroglobulinemia.
Current Hematologic Malignancy Reports , 2024
Approach to the patient with eosinophilia in the era of tyrosine kinase inhibitors and biologicals
J Lübke , G Metzgeroth , A Reiter , J Schwaab
Current Hematologic Malignancy Reports , 2024
MRD in Philadelphia Chromosome-Positive ALL: Methodologies and Clinical Implications
V Tran , K Salafian , K Michaels , ... , F El Chaer
Current Hematologic Malignancy Reports , 2024